Treatment of Hepatitis C Infections with Interferon: A Historical Perspective
Hepatitis Research and Treatment · 2010
DOI: 10.1155/2010/323926 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hepatitis Research and Treatment, 2010. Verfasst von Robert M Friedman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Interferons were first described in 1957, but it was not until 34 years after their discovery that sufficient quantities of it were available for treatment of hepatitis C virus (HCV) infections, Clinicians now have an excellent understanding of the basis for the effectiveness of interferon alpha (IFN-) in the therapy of this disease. Treatment with IFN- is more efficient when it complemented by the antiviral ribavirin and the IFN- is conjugated with polyethylene glycol to form peginterferon. In the near future treatment of HCV with IFN- may involve new anti-HCV agents that are currently under development.
Autor:innen und Institutionen
- Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
Zitieren
APA
Friedman, R. M., & Contente, S. (2010). Treatment of Hepatitis C Infections with Interferon: A Historical Perspective. Hepatitis Research and Treatment. https://doi.org/10.1155/2010/323926
Vancouver
Friedman RM, Contente S. Treatment of Hepatitis C Infections with Interferon: A Historical Perspective. Hepatitis Research and Treatment. 2010. doi:10.1155/2010/323926
BibTeX
@article{Friedman2010,
author = {Friedman, Robert M and Contente, Sara},
title = {Treatment of Hepatitis C Infections with Interferon: A Historical Perspective},
journal = {Hepatitis Research and Treatment},
year = {2010},
doi = {10.1155/2010/323926}
}
EUVIMED